Overview of Dr. Francis
Dr. Jasmine Francis is an ophthalmologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, New York Eye and Ear Infirmary of Mount Sinai, and Mount Sinai Beth Israel. She received her medical degree from New York University Grossman School of Medicine and has been in practice 10 years. She is one of 656 doctors at New York Eye and Ear Infirmary of Mount Sinai and one of 23 doctors at Memorial Sloan Kettering Cancer Center who specialize in Ophthalmology. She has more than 100 publications and over 500 citings.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
Icahn School of Medicine at Mount Sinai/New York Eye and Ear Infirmary at Mount SinaiResidency, Ophthalmology, 2008 - 2011
New York University School of MedicineClass of 2007
Certifications & Licensure
NY State Medical License 2008 - 2026- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 1 citationsPLASMA CIRCULATING TUMOR DNA TO ASSIST IN THE DIAGNOSIS OF UNKNOWN PRIMARY MALIGNANCY UNDERLYING CHOROIDAL METASTASES.Jasmine H Francis, Sara Levine, Julia Canestraro, Juliana Eng, David H Abramson
Retinal Cases & Brief Reports. 2025-01-01 - EVALUATING LARGE LANGUAGE MODELS ON THEIR ACCURACY AND COMPLETENESS: Immune Checkpoint Inhibitors and Their Ocular Toxicities.Camellia Edalat, Nila Kirupaharan, Lauren A Dalvin, Kapil Mishra, Rayna Marshall
Retina. 2025-01-01 - Phaeohyphomycosis, a Pigment-Producing Fungus, Mimicked Melanoma on External Examinations.Crystal W Law, William H Constad, Jasmine H Francis
Ophthalmology. 2024-12-21
Journal Articles
- Growth Patterns of Survivors of Retinoblastoma Treated with Ophthalmic Artery ChemosurgeryJasmine H Francis, Y Pierre Gobin, David H Abramson, PLoS One
- Total Retinal Detachments Due to Retinoblastoma: Outcomes Following Intra-Arterial chemotherapy/ophthalmic Artery ChemosurgeryIra J Dunkel, Jasmine H Francis, Y Pierre Gobin, Scott E Brodie, David H Abramson, PLoS One
- Clinical and Morphologic Characteristics of MEK Inhibitor–Associated RetinopathyJasmine Francis, MD, Ophthalmology
Press Mentions
Hearing Evaluations in Children with Retinoblastoma Treated with Intra-Arterial Carboplatin Chemotherapy: A Single Institution ReviewSeptember 10th, 2024- FDA Approves First Treatment for Patients with All Forms of HistiocytosisJanuary 30th, 2023
- Doctors Identify an Eye Cancer CulpritSeptember 13th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
